赛升药业(300485.SZ)：控股股东、实际控制人的一致行动人拟减持不超过2%股份

Core Viewpoint - Sai Sheng Pharmaceutical (300485.SZ) announced that its shareholders, Ma Li and Liu Shuqin, plan to reduce their holdings in the company by up to 9,633,328 shares within a specified timeframe, representing a maximum of 2% of the total share capital [1] Shareholding Details - Ma Li holds 29,846,791 shares, accounting for 6.2% of the total share capital of 481,666,400 shares [1] - Liu Shuqin holds 8,748,000 shares, representing 1.82% of the total share capital [1] - Both Ma Li and Liu Shuqin are acting in concert with the company's controlling shareholder, Ma Qiao [1] Reduction Plan - The planned reduction of shares will occur within three months, starting from 15 trading days after the announcement date, specifically from October 21, 2025, to January 20, 2026 [1] - The reduction will be executed through centralized bidding and block trading methods [1]